BABA Q1 2026 Earnings Massive EPS Miss Shakes Investor Confidence OTIS Q1 2026 Earnings EPS Misses Estimates by 185 as Market Digests Mixed Signals IMCR Q1 2026 Earnings Surprise Profitability Defies Expectations with No Reported Revenue Dyne Therapeutics Q1 2026 Earnings EPS Beat Amid Ongoing Clinical Focus APTV Q1 2026 Earnings Earnings Beat on Profitability Improvements